Peter Vanacker

Tenecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): Protocol for a randomized-controlled trial

Prior Reperfusion Strategy Does Not Modify Outcome in Early Versus Late Start of Anticoagulants in Patients With Ischemic Stroke: Prespecified Subanalysis of the Randomized Controlled ELAN Trial

R-tPA Resistance Is Specific for Platelet-Rich Stroke Thrombi and Can Be Overcome by Targeting Nonfibrin Components

Association between thrombus composition and first-pass recanalization after thrombectomy in acute ischemic stroke

Statin Therapy in Ischemic Stroke Patients with Atrial Fibrillation: Efficacy and Safety Outcomes

Early versus Later Anticoagulation for Stroke with Atrial Fibrillation

Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study

Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events

Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke

The impact of COVID-19 on acute stroke care in Belgium

Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance

Anticoagulation After Stroke in Patients With Atrial Fibrillation

Stroke coach: a pilot study of a personal digital coaching program for patients after ischemic stroke

Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)